Skip to main content
Premium Trial:

Request an Annual Quote

NextGen Sciences Enters Default in Suit Over Unpaid Wages

Premium

NextGen Sciences has entered default in a suit filed by six former employees alleging that the company and its officers Leif Hamoe and Thomas Borcholte failed to pay them wages owed for the period Aug. 1, 2012, through Oct. 10, 2012, totaling $115,002 (PM 1/11/2013).

The US District Court for the Eastern District of Michigan filed an entry of default last month after the company and Hamoe failed to plead or defend themselves in the suit. Both were served with papers on Dec. 18, 2012.

According to their complaint, the plaintiffs are seeking judgment against the defendants, "jointly and severally, in an amount in excess of $75,000 together with exemplary and statutory damages and their actual costs and attorney fees."

The plaintiffs said in their complaint that in June 2012 the defendants told them that payroll would not be met, and June compensation was not paid until July. July compensation was then not paid until August.

No compensation was paid for August or September, the plaintiffs alleged, noting that they "continued providing services" during these months "in reliance upon the representations and assurances of defendants that they would receive compensation for their services at their contractual rates."

They were then laid off in mid- October, and have yet to be paid the compensation owed them, they said.

In October, NextGen Sciences' parent company NextGen Group announced that due to an inability to secure additional financing it would likely take steps to wind down its business unless it was able in the near future to find a buyer for NextGen Sciences.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.